HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement GMP Inspections Slowing As FDA Makes 'Potential' Data Useful

This article was originally published in The Rose Sheet

Executive Summary

FDA doesn't expect o continue increasing GMP inspections at the rate established from fiscal 2013 through 2017, says Cara Welch, assistant director of the office in the agency's Office of Dietary Supplement Programs."We're not going to keep growing at that rate because we have a lot of regulations we have to inspect and we're always resource strapped," she said at a recent industry conference.

Advertisement

Related Content

Probiotic Safety Latest Target Of Supplement Regulation Critic Cohen
FDA Regulatory Oversight No Impediment To Drug-Spiked Supplements, Study Finds
US Supplement Market Growth: Is The Industry In Its Own Way?
FDA Litigates To Wash Off Sanitizer Ebola Claim, Warns On Colloidal Silver Benefits
Dietary Supplement Sector Warnings Jump With FDA 'Program Alignment'
Appropriators' Interest Could Point To FDA Supplement Programs Funding Boost

Topics

Advertisement
UsernamePublicRestriction

Register

RS121639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel